Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.

BACKGROUND AND PURPOSE Disease activity in normal-appearing white matter (NAWM) in multiple sclerosis (MS) has been demonstrated in vivo with T1 relaxation time measurements. We aimed to investigate the spatial distribution of T1 increases in MS NAWM without a priori selection of specific regions. METHODS Whole-brain quantitative T1 maps were measured in 67 patients with one of the 3 main clinical types of MS (13 primary progressive [PP], 36 relapsing-remitting [RR], and 18 secondary progressive [SP]) and in 23 healthy control subjects. After registration to standard space and segmentation of NAWM, the maps were analyzed by using voxel-based analyses with a cluster-based corrected P threshold of .05. RESULTS Group mean T1 relaxation times throughout NAWM increased when going from control subjects to PP to RR to SP MS. In the RR and SP MS groups, the T1 increases compared with control subjects were significant throughout the NAWM, without apparent preference for specific brain regions. In RR MS, 16% of NAWM voxels displayed a significant increase in T1 compared with control subjects, and in SP, this fraction was 49%. The comparison between RR MS and the subsequent phase SP MS revealed that, in these patients, disease progression occurs throughout the NAWM. In patients with PP MS, the spatial extent of significant T1 increases is limited. There were no correlations with clinical disability scales or brain volume in a substantial fraction of voxels. CONCLUSION This study demonstrates that in patients with RR MS and SP MS, NAWM disease processes have no regional preferences but can occur throughout the brain.

[1]  C. Caltagirone,et al.  T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis , 2004, Multiple sclerosis.

[2]  David H. Miller,et al.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.

[3]  Marco Rovaris,et al.  Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques , 2004, Multiple sclerosis.

[4]  G J Barker,et al.  Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.

[5]  Frederik Barkhof,et al.  Multislice T1 relaxation time measurements in the brain using IR‐EPI: Reproducibility, normal values, and histogram analysis in patients with multiple sclerosis , 2003, Journal of magnetic resonance imaging : JMRI.

[6]  R. Ordidge,et al.  High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.

[7]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[8]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[9]  P. Matthews,et al.  White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis , 2002, Journal of Neurology.

[10]  Paul S. Morgan,et al.  T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging , 2002, Journal of Neurology.

[11]  Marco Rovaris,et al.  Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.

[12]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[13]  G. Comi,et al.  Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI , 2002, Journal of Neurology.

[14]  Paul S. Morgan,et al.  White matter T1 relaxation time histograms and cerebral atrophy in multiple sclerosis , 2002, Journal of the Neurological Sciences.

[15]  M. Rovaris,et al.  Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging , 2002, Journal of the Neurological Sciences.

[16]  David H. Miller,et al.  The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis , 2002, Journal of Neurology.

[17]  F. Barkhof,et al.  Erratum: Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy (Journal of the Neurological Sciences 184 (2001) (155-162) PII: S0022510X01004312) , 2001 .

[18]  G J Barker,et al.  Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations , 2001, Neurology.

[19]  F. Barkhof,et al.  Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy , 2001, Journal of the Neurological Sciences.

[20]  P S Morgan,et al.  Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[21]  M. Rovaris,et al.  Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[22]  R Stollberger,et al.  A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[23]  G. Comi,et al.  Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.

[24]  M Cercignani,et al.  A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. , 2000, Archives of neurology.

[25]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[26]  M Rovaris,et al.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[27]  M Rovaris,et al.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[28]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[29]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[30]  G. Barker,et al.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.

[31]  E M Haacke,et al.  Accurate determination of spin‐density and T1 in the presence of RF‐field inhomogeneities and flip‐angle miscalibration , 1998, Magnetic resonance in medicine.

[32]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[33]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[34]  R I Grossman,et al.  Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.

[35]  Jonathan D. Cohen,et al.  Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold , 1995, Magnetic resonance in medicine.

[36]  M Filippi,et al.  A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.

[37]  Alan C. Evans,et al.  A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[39]  R. Steen,et al.  Age-related changes in the pediatric brain: proton T1 in healthy children and in children with sickle cell disease. , 2003, Magnetic resonance imaging.

[40]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[41]  C R Guttmann,et al.  A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. , 2001, Archives of neurology.

[42]  Karl J. Friston,et al.  Assessing the significance of focal activations using their spatial extent , 1994, Human brain mapping.